Sequoia Financial Advisors, LLC - NOVUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 18 filers reported holding NOVUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Sequoia Financial Advisors, LLC ownership history of NOVUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$23,000
-74.4%
22,5000.0%0.00%
-71.4%
Q1 2019$90,000
+150.0%
22,5000.0%0.01%
+75.0%
Q4 2018$36,000
-56.1%
22,500
+28.6%
0.00%
-50.0%
Q3 2018$82,000–17,500–0.01%–
 Download
Other shareholders
NOVUS THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Orbimed Advisors 2,537,110$14,842,0000.16%
Lyon Street Capital, LLC 40,766$238,0000.10%
ELEMENT CAPITAL MANAGEMENT LLC 24,764$145,0000.03%
Tower Research Capital LLC (TRC) 793$5,0000.00%
VANGUARD GROUP INC 42,803$251,0000.00%
UBS Group AG 391$2,0000.00%
D. E. Shaw & Co., Inc. 15,679$92,0000.00%
Nationwide Fund Advisors 2$00.00%
IFP Advisors, Inc 27$00.00%
BANK OF AMERICA CORP /DE/ 445$3,0000.00%
View complete list of NOVUS THERAPEUTICS INC shareholders